
Amyotrophic Lateral Sclerosis Type 16: FUS Gene
Degeneration of motor neurons in ALS16 is often traced to FUS gene mutations; sequencing can confirm the subtype and guide gene-targeted research.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Degeneration of motor neurons in ALS16 is often traced to FUS gene mutations; sequencing can confirm the subtype and guide gene-targeted research.

Calcium deposits build up in arteries during the first months of life in GACI2. Finding ABCC6 mutations supports early diagnosis, monitoring and carrier testing.

Mutations in genes for muscle and joint development leave the hands and feet contracted at birth in DA1B; testing separates it from other distal arthrogryposes.

Whole-exome sequencing identifies the DYNC2H1 mutations behind this constricted-ribcage ciliopathy, allowing diagnosis before severe respiratory failure sets in.

Genes that regulate heart rhythm, MYBPC3 among them, sit behind AFF15; family screening, tailored medication and exercise advice follow from a genetic result.

Genetic work on ASD8 describes a TLN2 suppressor variant that softens the effects of a TPM1 mutation, feeding into diagnosis, treatment planning and counseling.

Symptoms may stay hidden until adulthood, then appear as fatigue, breathlessness or arrhythmia; PKP2 testing can identify ASD9 in newborns and at-risk relatives.

Infants with AVSD4 may show breathing difficulty, poor weight gain and cyanosis, caused by an atrioventricular septum that fails to form and a single common valve.